欧盟HMA药品数据库（European Union HMA Authorisation of Medicines DataBase）
MR编号
NL/H/1582/002
药品名称
Irbesartan/Hydrochloorthiazide 1A Pharma 300/12,5 mg, filmomhulde tabletten
活性成分
hydrochlorothiazide 12.5 mg
irbesartan 300.0 mg
剂型
Film-coated tablet
上市许可持有人
1A Pharma GmbH Keltenring 1 + 3 82041 Oberhaching Germany
参考成员国 - 产品名称
Netherlands (NL)
互认成员国 - 产品名称
Germany (DE)
许可日期
2011/03/07
最近更新日期
2024/03/19
药物ATC编码
C09DA04 irbesartan and diuretics
申请类型
TypeLevel1：
Abridged
TypeLevel2：
Initial Application
TypeLevel3：
Generic Art 10.1 and 10.2 Dir 2001/83/EC
TypeLevel4：
Chemical Substance
TypeLevel5：
Prescription Only
附件文件下载
Final Product Information
|
Irbesartan IA Pharma_1_3_1 spc_label_pl _ common_spc _ clean_ 300 mg 12_5 mg
Date of last change:2022/06/02
Final Product Information
|
Irbesartan IA Pharma_1_3_1 spc_label_pl _ common_outer _ clean _ 150 mg 12_5
Date of last change:2022/06/02
Final Product Information
|
Irbesartan IA Pharma_1_3_1 spc_label_pl _ common_pl _ clean _ 150 mg 12_5
Date of last change:2022/06/02
Final Product Information
|
Irbesartan IA Pharma_1_3_1 spc_label_pl _ common_spc _ clean _ 150 mg 12_5 mg
Date of last change:2022/06/02
Final Product Information
|
Irbesartan IA Pharma_1_3_1 spc_label_pl _ common_spc _ clean _ 300 mg 25 mg
Date of last change:2022/06/02
Final Product Information
|
Irbesartan IA Pharma_1_3_1 spc_label_pl _ common_pl _ clean_ 300 mg 25 mg
Date of last change:2022/06/02
Final Product Information
|
Irbesartan IA Pharma_1_3_1 spc_label_pl _ common_pl _ clean _ 300 mg 12_5
Date of last change:2022/06/02
Final Product Information
|
Irbesartan IA Pharma_1_3_1 spc_label_pl _ common_outer _ clean _ 300 mg 12_5 mg
Date of last change:2022/06/02
Final Product Information
|
Irbesartan IA Pharma_1_3_1 spc_label_pl _ common_outer _ clean_ 300 mg 25 mg
Date of last change:2022/06/02
Final PL
|
common PIL 150-12
Date of last change:2017/11/21
Final SPC
|
common SmPC 150-12
Date of last change:2017/11/21
Final SPC
|
NL SmPC 300-12
Date of last change:2017/11/21
Final SPC
|
common SmPC
Date of last change:2017/11/21
Final Labelling
|
common label
Date of last change:2017/11/21
Final PL
|
common PIL 300-12
Date of last change:2017/11/21
Final PL
|
common PIL
Date of last change:2017/11/21
Final Labelling
|
common label 150-12
Date of last change:2017/11/21
Final Labelling
|
common label 300-12
Date of last change:2017/11/21
PAR
|
PAR_1582_DC_20 May 2010
Date of last change:2014/02/10
市场状态
Positive
©2006-2024
Drugfuture
->
European Union HMA Authorisation of Medicines DataBase